Guangdong Biolight Meditech (300246.SZ) Earnings Analysis

Guangdong Biolight Meditech (300246.SZ) has no confirmed upcoming earnings date. Trailing P/E -51.12.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does 300246.SZ next report earnings?

No confirmed upcoming earnings date is currently scheduled for 300246.SZ. This page updates as the calendar is published.

300246.SZ earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-04-25-0.23 CNYn/an/an/a
2025-10-25-0.03691 CNYn/an/an/a
2025-04-24-0.21928 CNYn/an/an/a
2025-03-310.0546 CNYn/an/an/a
2024-10-27-0.04253 CNYn/an/an/a
2024-08-28-0.02338 CNYn/an/an/a

300246.SZ valuation and analyst view

Trailing P/E-51.12
Trailing EPS-0.34856 CNY
Price / book4.07
Dividend yield0.28%
Market cap4.25B

Limited or no published sell-side analyst coverage for this symbol.

Related research pages

Frequently asked questions

When is Guangdong Biolight Meditech (300246.SZ)'s next earnings date?

No confirmed upcoming earnings date is currently scheduled for 300246.SZ. This page updates as the calendar is published.

Did 300246.SZ beat earnings last quarter?

Consensus estimate data was not available for 300246.SZ's 2026-04-25 report.

What is 300246.SZ's current P/E ratio and EPS?

300246.SZ trades at a trailing P/E of -51.12 on trailing EPS of -0.34855794860039235 CNY.

What do analysts rate 300246.SZ?

300246.SZ has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.